DocuSign: Early-Stage Pricing Experiments Create Uncertain Upside, Justifying a Hold Rating

Needham analyst Scott Berg has maintained their neutral stance on DOCU stock, giving a Hold rating on March 7.

Scott Berg’s rating is based on the early and uncertain nature of DocuSign’s current pricing and packaging experiments. Management has confirmed it is testing higher pricing for the eSignature Professional tier, paired with unlimited envelopes and added AI-driven contract analysis, but has not yet committed to a final structure or timeline.

Given the lack of concrete data on customer adoption, elasticity, and competitive response, Berg views the financial impact as difficult to quantify at this stage. He acknowledges that successful pricing changes could support revenue growth in fiscal 2027 and 2028, but believes the risk‑reward profile is balanced for now, leading him to maintain a Hold stance on the shares.

In another report released on March 7, TipRanks – Google also reiterated a Hold rating on the stock with a $52.00 price target.